SCHEMBL6130801

SCHEMBL6130801

CCCCC(O)(CCCC)C(O)CO

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.34
ALDH1A1 P00352 3/20 0.34
CYP2D6 P10635 2/20 0.33
SPHK1 Q9NYA1 1/20 0.33
GMNN O75496 1/20 0.33
POLB P06746 1/20 0.33
THPO P40225 1/20 0.33
MTOR P42345 1/20 0.33
BLM P54132 1/20 0.33
KDM4E B2RXH2 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
CETP P11597 1/20 0.33
HTT P42858 1/20 0.33
UBE2N P61088 1/20 0.33
USP2 O75604 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
FDPS P14324 6/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2039696 0.93 FDPS (0.39) LMNACYP2D6SPHK1GMNNPOLB
SCHEMBL302211 0.93 FDPS (0.39) LMNACYP2D6SPHK1GMNNPOLB
SCHEMBL136611 0.91 LMNA (0.41) LMNAALDH1A1CYP2D6SPHK1GMNN
SCHEMBL142854 0.91 LMNA (0.41) LMNAALDH1A1CYP2D6SPHK1GMNN
SCHEMBL139952 0.91 LMNA (0.41) LMNAALDH1A1CYP2D6SPHK1GMNN
SCHEMBL25815 0.91 LMNA (0.41) LMNAALDH1A1CYP2D6SPHK1GMNN
SCHEMBL5963212 0.91 LMNA (0.41) LMNAALDH1A1CYP2D6SPHK1GMNN
SCHEMBL1890334 0.91 LMNA (0.41) LMNAALDH1A1CYP2D6SPHK1GMNN
SCHEMBL2226505 0.91 LMNA (0.41) LMNAALDH1A1CYP2D6SPHK1GMNN
SCHEMBL18863212 0.91 LMNA (0.41) LMNAALDH1A1CYP2D6SPHK1GMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104988187-B Production of peracids using enzymes having perhydrolytic activity 纳幕尔杜邦公司 2021-02-05 CN claimed
US-20230277555-A1 STEROID HORMONE PHARMACEUTICAL FORMULATIONS THERAPEUTICSMD INC (US) 2023-09-07 US disclosed
US-11633405-B2 Steroid hormone pharmaceutical formulations THERAPEUTICSMD, INC. (US) 2023-04-25 US disclosed
US-20210244747-A1 STEROID HORMONE PHARMACEUTICAL FORMULATIONS THERAPEUTICSMD, INC. 2021-08-12 US disclosed
CN-104988187-B Production of peracids using enzymes having perhydrolytic activity 纳幕尔杜邦公司 2021-02-05 CN disclosed
CN-104350154-B Enzymes useful for peracid production 纳幕尔杜邦公司 2020-12-29 CN disclosed
US-9069133-B2 Anti-reflective coating for photolithography and methods of preparation thereof HONEYWELL INTERNATIONAL INC. (US) 2015-06-30 US disclosed
US-20140227538-A1 Anti-Reflective Coating for Photolithography and Methods of Preparation Thereof HONEYWELL INTERNATIONAL INC. (US) 2014-08-14 US disclosed
EP-1478682-A4 ANTI-REFLECTIVE COATINGS FOR PHOTOLITHOGRAPHY AND METHODS OF PREPARATION THEREOF HONEYWELL INT INC (US) 2005-06-15 EP disclosed
CN-1615332-A Antireflective coatings for photolithography and methods of making the same HONEYWELL INT INC (US) 2005-05-11 CN disclosed
EP-1478682-A1 ANTI-REFLECTIVE COATINGS FOR PHOTOLITHOGRAPHY AND METHODS OF PREPARATION THEREOF Honeywell International, Inc. (US) 2004-11-24 EP disclosed
WO-2004044025-A2 ANTI-REFLECTIVE COATINGS FOR PHOTOLITHOGRAPHY AND METHODS OF PREPARATION THEREOF HONEYWELL INTERNATIONAL INC (US) 2004-05-27 WO disclosed
WO-2003044078-A9 ANTI-REFLECTIVE COATINGS FOR PHOTOLITHOGRAPHY AND METHODS OF PREPARATION THEREOF HONEYWELL INT INC (US) 2004-01-08 WO disclosed
WO-2003044078-A1 ANTI-REFLECTIVE COATINGS FOR PHOTOLITHOGRAPHY AND METHODS OF PREPARATION THEREOF HONEYWELL INTERNATIONAL INC. (US) 2003-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210244747-A1 STEROID HORMONE PHARMACEUTICAL FORMULATIONS SHBG, NR5A1, HSD17B11 LMNA 2712/4885ALDH1A1 3884/4885CYP2D6 124/4885
US-11633405-B2 Steroid hormone pharmaceutical formulations SHBG, NR5A1, HSD17B11 LMNA 2712/4885ALDH1A1 3884/4885CYP2D6 124/4885
US-20230277555-A1 STEROID HORMONE PHARMACEUTICAL FORMULATIONS SHBG, NR5A1, HSD17B11 LMNA 2712/4885ALDH1A1 3884/4885CYP2D6 124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.